SCHEMBL25420920

SCHEMBL25420920

CN(C)c1ccc(C#Cc2ccc3c4c(cccc24)C(=O)N(CCOCCO)C3=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.47
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ POLB P06746 4/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PABPC1 P11940 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ AVPR1A P37288 1/20 0.39
▸ HEXA P06865 2/20 0.36
▸ HEXB P07686 2/20 0.36
▸ CCR6 P51684 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ RPS6KB1 P23443 1/20 0.36
▸ EPHA2 P29317 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26555732 0.94 APP (0.43) APPMEN1KMT2APOLBNPC1
SCHEMBL25417476 0.84 HEXA (0.46) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL30436709 0.84 HEXA (0.46) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL25421298 0.82 TERT (0.49) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL3503679 0.79 MEN1 (0.60) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL26555003 0.75 TYMS (0.44) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL29449407 0.74 MEN1 (0.50) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL10262375 0.73 CYP1B1 (0.60) MEN1KMT2APOLBNPC1MAPT
SCHEMBL10262050 0.73 LMNA (0.59) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL16085240 0.73 KEAP1 (0.60) MEN1KMT2APOLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2023-10-19 — — US claimed
EP-4185567-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2023-05-31 — — EP claimed
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2023-10-19 — — US disclosed
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2023-10-19 — — US disclosed
EP-4185567-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2023-05-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF PSEN1, PSEN2, MAPT APP 5/4885MEN1 521/4885KMT2A 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback